Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Post by general360on Nov 04, 2020 2:37pm
272 Views
Post# 31836564

cost basis

cost basis
boy oh boy is it a mess....does anyone know what the cost basis of RVX and ZEN is?

from the spin out, looks like the shares left behind are all out of whack... i havent looked too closely - until now-
the zen capital corp vs zen capital corporation also seems to be throwing a monkey wrench into it.  i just spent about 30m on the phone w/ broker, still not sure i fully understand but as per usual, my understanding isnt important!  what is, is that the brokerage says everything is fine....

cost basis was explained as:  post split = 1% rvx and 99% zen?   so they took my shares, total price, allocated 1% of it to RVXCF and divided by total number of shares, giving me a new cost basis for RVXCF.  looks like i was a mad genius and paid .02 to .04 cents per share back in 2010 and 2013.  They took 99% of total price, divided by same shares and came up with some crazy #'s. the same lots of zen show up w/ a cost basis of $24 to 34$.  im scratching my head cause i think these were bought in the $2/$3/$4 range...

also showing zhclf is trading.  they think its correct, but i tried to explain the zen cap corp vs zen capital corporation but i dont think thats working.  they think it's an epigenetics company  in name so it must be right?!?!  there are no assurances that i can get shares of this now, and eventually when someone figures the spaghetti out - will i still have all these shares in actual zen epigenetics?!? i guess the good news is i'm apparently so far under water based on their calculations, i'll lose money unless we sell zen for more than 34$/share. i'll have to play with the numbers and see who's who is da zoo...the zen FAQ doesn't help in this case i dont think.  i asked if i bought a whole bunch of shares of ZHCLF now, when this gets untangled, will i still have shares in zen epi, or would it get unwound?  the answer was there are no assurances.  i'm not willing to lock up more money for YEARS more, but i wonder what would happen - buy this zhclf for 4 pennies when they're doing PP's for 1.50?


conversely, apparently i'm sitting on some very large paper gains since i bought this in 2010 and 2013 at MY TWO CENTS!!

is nothing easy w/ this company?!?!?! / companies??

the good news (MORE good news GENERAL?!) is that this isn't an issue until i sell.  the bad news is that we're still held ZEN hostage since its not trading!  kick the can down the road DM style and deal w/ it later, at sale/tax time...  hey, that's an excuse, maybe DM is better off never listing ZEN so he doesnt cause us all this book keeping headache!! or dont make a RVX deal so u dont give us a large tax bill, or push the deal into the new year so ppl can put more into ur RRSP...

GET. IT. DONE.
<< Previous
Bullboard Posts
Next >>